BCL2L1 and neoplasm: The anti-tumor drug actinomycin D caused less cell death and caspase-3/7 activation in Bcl-2-, Mcl-1- or Bcl-xL-overexpressing cells than in cells expressing the empty vector (Figure 2B–2C and Supplementary Figure 4B–4C and 4E–4F).